Human Virology and Viral Diseases
A section of Viruses (ISSN 1999-4915).
Section Information
Viruses have caused some of the most dramatic and deadly disease pandemics and epidemics the world has known. Subsequently, most of these causing agents have become common viruses with different epidemiological trends. The most recent trend has focused on emerging and re-emerging viruses and our related preparedness and response aspects. However, human virology goes beyond (re)-emerging viral diseases. This section aims at addressing all aspects of human viruses, medical virology and virus-induced clinical diseases. All types of manuscripts addressing a broad range of topics including epidemiology, prevention, diagnostics and treatment, will be considered in this section. Manuscripts must represent original and significant contributions.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- HIV Assembly, Release and Maturation (Deadline: 30 November 2024)
- HPV-Associated Cancers (Deadline: 30 November 2024)
- Congenital Cytomegalovirus Infection: Volume II (Deadline: 30 November 2024)
- HIV Neurological Disorders: 2nd Edition (Deadline: 30 November 2024)
- Hepatitis B Surface Antigen: A Pivotal Role in the Virus–Host Interactions (Deadline: 30 November 2024)
- Cascade of Care for HIV and Hepatitis (Deadline: 30 November 2024)
- APOBECs and Virus Restriction 2024 (Deadline: 1 December 2024)
- Human T-Cell Leukemia Virus (HTLV) Infection and Treatment (Deadline: 15 December 2024)
- Cellular Mechanisms Regulating HIV Replication (Deadline: 15 December 2024)
- Virological and Immunological Factors Underlying HBV Functional Cure and HBV Reactivation (Deadline: 15 December 2024)
- Molecular Biology of Human Cytomegalovirus (Deadline: 20 December 2024)
- Human Norovirus 2024 (Deadline: 20 December 2024)
- HIV and Tuberculosis (TB) Coinfection (Deadline: 20 December 2024)
- Viral Hepatitis in Latin America and the Caribbean (Deadline: 30 December 2024)
- Impact of Pandemic Measures on the Epidemiology and Seasonality of Other Viruses (Deadline: 31 December 2024)
- Novel Strategies to Identify and Eliminate Latent HIV Cells (Deadline: 31 December 2024)
- Hantavirus 2024 (Deadline: 31 December 2024)
- Hepatitis C Virus Infection among People Who Inject Drugs (Deadline: 31 December 2024)
- Papillomavirus-Induced Oncogenesis: Current Insights and Future Directions (Deadline: 31 December 2024)
- Zika Virus and Congenital Zika Syndrome (Deadline: 31 December 2024)
- Viral Hepatitis and Liver Diseases (Deadline: 31 December 2024)
- Immune Modulation by Human Cytomegalovirus (Deadline: 31 December 2024)
- Human Adenovirus (HAdV) Infection in Children (Deadline: 31 December 2024)
- Hepatitis C Virus 2024 (Deadline: 31 December 2024)
- Maternal to Child Transmission of HIV and the Effects on Pregnancy (Deadline: 31 December 2024)
- Beyond Acute: Navigating Long COVID and Post-Viral Complications (Deadline: 15 January 2025)
- HIV and Viral Hepatitis Co-Infection (Deadline: 31 January 2025)
- JC Polyomavirus (Deadline: 31 January 2025)
- Enteric Viruses, Bacteria, and the Virome in Health and Disease (Deadline: 31 January 2025)
- The Influence of COVID-19 Pandemic on the Epidemiology of Other Human Viral Infections (Deadline: 31 January 2025)
- Saliva in the Diagnosis of Viral Diseases (Deadline: 31 January 2025)
- Viral Infections in Immunocompromised Hosts (Deadline: 31 January 2025)
- Enteroviruses: Respiratory and Nervous System Infections (Deadline: 31 January 2025)
- Hepatitis Viral Infections, Pathogenesis and Therapeutics (Deadline: 1 February 2025)
- Viruses and Eye Diseases (Deadline: 28 February 2025)
- Hepatitis E: Molecular Virology, Pathogenesis, and Treatment, 2nd Edition (Deadline: 28 February 2025)
- Preparation for the Next Potential Pandemic—Chikungunya, Dengue, Zika and Other Viruses (Deadline: 28 February 2025)
- Mosquito-Borne Encephalitis Viruses (Deadline: 28 February 2025)
- Progress and Prospects in Oncolytic Virotherapy (Deadline: 28 February 2025)
- Viral Infections in Special Populations (Deadline: 28 February 2025)
- Viral Hepatitis Coinfection (Deadline: 28 February 2025)
- Epidemiology, Pathogenesis and Immunity of Adenovirus (Deadline: 6 March 2025)
- BSL4 Viruses: Understanding and Controlling Highly Infectious Pathogens (Deadline: 15 March 2025)
- Current ART, Virologic Failure and Implications for HIV Drug Resistance, 2nd Edition (Deadline: 31 March 2025)
- Viruses Associated with Gastroenteritis (Deadline: 31 March 2025)
- RSV Epidemiological Surveillance: 2nd Edition (Deadline: 31 March 2025)
- Advances in Research on HIV Drug Resistance and Other Determinants of Treatment Success: 3rd Edition (Deadline: 31 March 2025)
- Emerging and Re-emerging Infections: Impact on Substances of Human Origin (SoHO) (Deadline: 31 March 2025)
- HIV Vaccines: Bridging the Gap Between Basic Science and Clinical Practice (Deadline: 31 March 2025)
- HIV-1 Infection and Immunometabolism: Relevance to HIV Pathogenesis and Persistence 3.0 (Deadline: 31 March 2025)
- Understanding the Oncogenesis of Human Herpesviruses through Their Critical Comparisons (Deadline: 25 April 2025)
- Molecular and Cellular Biology of Human Oncogenic Viruses (Deadline: 30 April 2025)
- Intra-patient Viral Evolution (Deadline: 30 April 2025)
- Human Cytomegalovirus Therapeutic Strategies and Clinical Applications (Deadline: 30 April 2025)
- EBV and Disease: New Perspectives in the Post COVID-19 Era (Deadline: 30 April 2025)
- Hepatitis B Core-Related Antigen (Deadline: 30 April 2025)
- Coxsackieviruses, Polioviruses and Associated Diseases (Second Edition) (Deadline: 1 May 2025)
- Research and Clinical Application of Adenovirus (AdV), 3rd Edition (Deadline: 25 May 2025)
- Endogenous Retrovirus Proteins and Their Functions, 2nd Edition (Deadline: 30 May 2025)
- TMPRSS2 in Influenza Virus and Coronavirus Infections (Deadline: 31 May 2025)
- Severe Fever with Thrombocytopenia Syndrome Virus 2025 (Deadline: 31 May 2025)
- Oropouche Virus (OROV): An Emerging Peribunyavirus (Bunyavirus) (Deadline: 1 June 2025)
- Immune Responses to Papillomavirus Infections: 2nd Edition (Deadline: 30 June 2025)
- Advancing Research of Anelloviruses, Second Edition (Deadline: 30 June 2025)
- Viral Infection and Platelets’ Disorders (Deadline: 30 June 2025)
- Herpesviruses and Associated Diseases (Deadline: 31 July 2025)
- Viral Infections in Gynecological Diseases (Deadline: 31 August 2025)
- Viral Immunology in Transplant Patients (Deadline: 31 August 2025)
- Human and Animal Papillomavirus: Infections, Genetics, and Vaccines (Deadline: 10 September 2025)
- HIV and HTLV Infections and Coinfections (Deadline: 30 September 2025)
- Neurocognitive Dynamics and Biomarkers in HIV (Deadline: 1 November 2025)
- Molecular Mechanisms and Clinical Manifestations of Persistent Viral Infections (Deadline: 30 November 2025)
- HIV Reservoirs, Latency, and the Factors Responsible (Deadline: 31 December 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
